InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: hschlauch post# 43129

Friday, 03/09/2018 4:26:43 PM

Friday, March 09, 2018 4:26:43 PM

Post# of 48316
Yes, it seems obvious that the TNBC Pilot study yielded very compelling data for Oncosec to do a quick 23 mil equity raise to get a phaseII TNBC trial under way. I would think the collaborator would obviously be Bristol Myers since the two patients were dosed with Opdivo. Looking forward to abstracts released for AARC next week, then we will know for sure if Oncosec is presenting the detailed data there next month.